Suscribirse

Postoperative chyle leak after pancreatic surgery – Is treatment effective? - 20/05/21

Doi : 10.1016/j.jviscsurg.2021.03.011 
M. Weniger 1, J.G. D’Haese 1, E. Bidlingmaier, S. Becker, M. Ilmer, M.K. Angele, W. Hartwig, J. Werner
 Department of general, visceral, and transplantation surgery, Ludwig-Maximilians University, Marchioninistraße 15, 81377 Munich, Germany 

Corresponding author.
En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Thursday 20 May 2021
This article has been published in an issue click here to access

Highlights

Chyle leak prolongs length of stay.
Prediction of chyle leak was not possible using parameters of the performed surgery.
Dietary treatment did not reduce morbidity or time to drain removal.
Patients un- or under-treated for CL did not experience CL-associated morbidity within 3 months postoperatively.

El texto completo de este artículo está disponible en PDF.

Summary

Purpose

With increasing soft tissue clearance in pancreatic cancer surgery, postoperative chyle leak (CL) has become a more commonly observed complication. Recently, a new consensus definition was established by the International study group of pancreatic surgery (ISGPS). The aim of the present analysis was to evaluate risk factors and treatment options of patients with CL after pancreatic surgery.

Methods

Two hundred and twenty-eight patients with serous or chylous drainage after pancreatic surgery were included in this analysis of a prospectively collected database between 01/2014 and 12/2016. Risk factors for CL and treatment options were compared. A subgroup analysis on those patients, who had drain removal despite of persistent CL with respect to the need of subsequent percutaneous drainage or reoperation within three months postoperatively, was performed.

Results

Sixty patients with CL were identified. Of those, 41 patients were treated with medium-chain triglyceride-diet, with a median duration of therapy of 12 days. In patients with CL, the type of treatment had no effect on time to drain removal (P=0.29) and morbidity (P=0.15). Furthermore, morbidity was not increased in patients who had their drains removed despite persistent CL (P=0.84). None of the latter patients had percutaneous drainage or reoperation for CL after removal of the surgical drains.

Conclusions

Dietary treatment may not be very effective in treating CL. Further research is warranted to explore the effect and necessity of CL treatment.

El texto completo de este artículo está disponible en PDF.

Keywords : Chylous ascites, Total parenteral nutrition, MCT-diet


Esquema


 Previous presentations at meetings and conferences: Data from this study were presented at the European pancreatic club in Budapest 2017 (abstract published in Pancreatology, j.pan.2017.05.216), German pancreatic club in Greifswald 2017, at the annual meeting of the Association of Bavarian surgeons 2017 and the annual meeting for Visceral medicine in Dresden 2017.


© 2021  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.